EC Number   |
Substrates |
Organism |
Products |
Reversibility |
|---|
   1.10.5.1 | 1-(beta-D-ribofuranosyl)-1,4-dihydronicotinamide + a quinone |
- |
Homo sapiens |
1-(beta-D-ribofuranosyl)nicotinamide + a hydroquinone |
- |
? |
| 1.10.5.1 | 1-(beta-D-ribofuranosyl)-1,4-dihydronicotinamide + a quinone |
- |
Homo sapiens |
1-(beta-D-ribofuranosyl)nicotinamide + a quinol |
- |
? |
| 1.10.5.1 | 1-(beta-D-ribofuranosyl)-1,4-dihydronicotinamide + co-enzyme Q |
natural substrate nicotinamide riboside, NRH |
Homo sapiens |
1-(beta-D-ribofuranosyl)nicotinamide + reduced co-enzyme Q |
- |
? |
| 1.10.5.1 | 1-(beta-D-ribofuranosyl)-1,4-dihydronicotinamide + menadione |
- |
Homo sapiens |
1-(beta-D-ribofuranosyl)nicotinamide + menadiol |
- |
? |
| 1.10.5.1 | 1-(beta-D-ribofuranosyl)-1,4-dihydronicotinamide + menadione |
natural substrate nicotinamide riboside, NRH |
Homo sapiens |
1-(beta-D-ribofuranosyl)nicotinamide + menadiol |
- |
? |
| 1.10.5.1 | 1-(carbamoylmethyl)dihydronicotinamide + 3-hydroxy-1-methylindoline-5,6-dione |
3-hydroxy-1-methylindoline-5,6-dione i.e. adrenochrome |
Rattus norvegicus |
1-(carbamoylmethyl)nicotinamide + 3-hydroxy-1-methylindoline-5,6-diol |
- |
? |
| 1.10.5.1 | 1-benzyl-1,4-dihydronicotinamide + estradiol-3,4-quinone |
- |
Homo sapiens |
1-benzyl-3-carbamoylpyridinium + estrone-3,4-quinone |
- |
r |
| 1.10.5.1 | 1-carbamoylmethyl-3-carbamoyl-1,4-dihydropyrimidine + menadione |
- |
Homo sapiens |
1-carbamoylmethyl-3-carbamoylpyrimidine + menadiol |
- |
? |
| 1.10.5.1 | 17beta-17-hydroxyestr-1(10)-ene-3,4-dione + N-benzyldihydronicotinamide |
ping-pong mechanism, NQO2 is faster in reducing estrogen quinones than its homologue NQO1 |
Homo sapiens |
17beta-estra-1(10),2,4-triene-3,4,17-triol + N-benzylnicotinamide |
- |
? |
| 1.10.5.1 | 2,6-dichloroindophenol + dihydronicotinamide riboside |
- |
Mus musculus |
? + nicotinamide riboside |
- |
? |
